JD HEALTH
06618
JD-SW
09618
BEKE-W
02423
TRIP.COM-S
09961
NTES-S
09999
(Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | (Q6)Jun 30, 2020 | (FY)Dec 31, 2019 | |
---|---|---|---|---|---|---|---|---|---|---|
Net interest income | 23.00%137.1M | 5.23%238.84M | 0.86%111.46M | -6.86%226.97M | -7.38%110.51M | 11.81%243.7M | 5.11%119.32M | -11.12%217.96M | -10.72%113.51M | -2.12%245.25M |
-Interest income | 29.56%166.68M | 8.01%279.58M | 2.82%128.65M | -3.87%258.85M | -5.22%125.13M | 7.35%269.28M | -0.35%132.02M | -16.19%250.84M | -13.45%132.49M | -1.93%299.29M |
-Interest expense | -72.07%-29.58M | -27.80%-40.74M | -17.61%-17.19M | -24.63%-31.88M | -15.06%-14.62M | 22.21%-25.58M | 33.05%-12.71M | 39.16%-32.88M | 26.83%-18.98M | 1.08%-54.05M |
Net service income | 1.95%-181.75M | -2.37%-366.82M | -5.32%-185.37M | -297.10%-358.32M | -308,877.19%-176M | -9,972.43%-90.23M | 112.81%57K | -78.19%914K | -164.40%-445K | 819.08%4.19M |
-Service income | -61.93%158K | -38.77%908K | -62.14%415K | -69.36%1.48M | -41.11%1.1M | -31.32%4.84M | -45.43%1.86M | -76.72%7.05M | -79.61%3.41M | 661.47%30.28M |
-Service charge | 2.09%-181.91M | -2.20%-367.73M | -4.90%-185.78M | -278.45%-359.8M | -9,717.02%-177.1M | -1,450.20%-95.07M | 53.20%-1.8M | 76.49%-6.13M | 75.95%-3.86M | -641.05%-26.09M |
Securities and investments income | -69.50%1.22M | 124.77%1.8M | 1,496.50%3.99M | ---7.26M | ---286K | ---- | ---- | ---4.92M | ---- | ---- |
Special items of operating revenue | -6.43%143.96M | 0.22%297.24M | 10.34%153.85M | 404.88%296.6M | 375.80%139.43M | 148.21%58.75M | 39.63%-50.56M | -34.18%-121.85M | -149.27%-83.74M | -6.11%-90.81M |
Operating revenue | 19.76%100.52M | 8.27%171.05M | 13.97%83.94M | -25.55%157.99M | 7.02%73.65M | 130.39%212.21M | 134.67%68.82M | -41.93%92.11M | -68.88%29.32M | 8.09%158.63M |
Special items before deducting impairment | -8.56%-43.18M | -9.38%-80.74M | -15.24%-39.77M | -17.35%-73.82M | -9.93%-34.51M | -19.48%-62.91M | -9.10%-31.4M | 25.11%-52.65M | 21.30%-28.78M | 4.64%-70.3M |
Operating profit before deducting impairment | 29.84%57.34M | 7.29%90.31M | 12.85%44.17M | -43.62%84.17M | 4.58%39.14M | 278.35%149.31M | 6,728.65%37.42M | -55.32%39.46M | -99.05%548K | 20.95%88.33M |
Impairment and provisions | -16.94%-46.14M | -13.60%-84.87M | 1.28%-39.45M | 51.44%-74.71M | 30.78%-39.97M | -23.06%-153.85M | ---57.74M | ---125.02M | ---- | ---- |
-Impairment losses of other assets | -16.94%-46.14M | -13.60%-84.87M | 1.28%-39.45M | 51.44%-74.71M | 30.78%-39.97M | -23.06%-153.85M | ---57.74M | ---125.02M | ---- | ---- |
Operating profit after deducting impairment | 137.84%11.21M | -42.55%5.44M | 667.71%4.71M | 308.21%9.46M | 95.91%-830K | 94.69%-4.54M | -3,807.48%-20.32M | -196.86%-85.55M | -99.05%548K | 20.95%88.33M |
Special items of operating profit | 13.73%45.95M | 10.08%83.98M | -3.16%40.4M | -49.50%76.29M | --41.72M | --151.06M | ---- | ---- | ---- | ---- |
Operating profit | 26.69%57.16M | 4.28%89.42M | 10.33%45.11M | -41.47%85.75M | 301.26%40.89M | 271.25%146.51M | -3,807.48%-20.32M | -196.86%-85.55M | -99.05%548K | 20.95%88.33M |
Share of profits of associates | ---- | 30.71%2.24M | ---- | --1.72M | ---- | ---- | ---- | ---- | ---- | ---- |
Share of profit from joint venture company | ---- | ---- | --2.13M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Special items of earning before tax | ---- | ---- | ---- | ---- | ---- | ---- | 373.16%55.46M | 4,758.10%107.36M | 384.93%11.72M | -94.15%2.21M |
Earning before tax | 20.97%57.16M | 4.79%91.66M | 15.55%47.25M | -40.30%87.47M | 16.34%40.89M | 571.77%146.51M | 186.45%35.15M | -75.91%21.81M | -77.09%12.27M | -18.28%90.54M |
Tax | -36.01%-14.58M | 7.83%-25M | 13.53%-10.72M | 40.78%-27.12M | -2.62%-12.4M | -280.45%-45.8M | -61.36%-12.08M | 53.06%-12.04M | 47.84%-7.49M | 32.51%-25.64M |
After-tax profit from continuing operations | 16.56%42.58M | 10.47%66.66M | 28.20%36.53M | -40.08%60.35M | 23.53%28.49M | 930.64%100.71M | 382.31%23.06M | -84.94%9.77M | -87.80%4.78M | -10.86%64.89M |
Earning After tax | 16.56%42.58M | 10.47%66.66M | 28.20%36.53M | -40.08%60.35M | 23.53%28.49M | 930.64%100.71M | 382.31%23.06M | -84.94%9.77M | -87.80%4.78M | -10.86%64.89M |
Minority profit | 34.33%11.97M | 4.78%20.21M | -13.87%8.91M | 42.42%19.29M | 24.79%10.34M | 79.26%13.55M | 113.11%8.29M | -47.76%7.56M | -51.79%3.89M | 22.52%14.46M |
Profits attributable to shareholders | 10.83%30.61M | 13.14%46.45M | 52.18%27.62M | -52.90%41.06M | 22.83%18.15M | 3,833.62%87.17M | 1,554.65%14.78M | -95.61%2.22M | -97.13%893K | -17.32%50.43M |
Basic earnings per share | 12.00%0.028 | 13.16%0.043 | 47.06%0.025 | -52.50%0.038 | 21.43%0.017 | 3,900.00%0.08 | 1,300.00%0.014 | -95.65%0.002 | -96.55%0.001 | -17.86%0.046 |
Diluted earnings per share | 12.00%0.028 | 13.16%0.043 | 47.06%0.025 | -52.50%0.038 | 30.77%0.017 | 3,900.00%0.08 | 1,200.00%0.013 | -95.65%0.002 | -96.43%0.001 | -17.86%0.046 |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
Auditor | -- | Rosenmei Certified Public Accountants | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.